This grant, offered by the Alzheimer’s Drug Development Program, aims to accelerate the creation of novel treatments for Alzheimer’s disease (AD). Its primary purpose is to provide crucial funding support for the pre-clinical and early-stage clinical (Phase I) development of new small-molecule and biologic drug candidates. This initiative specifically targets innovative therapies designed to prevent the onset of AD, significantly slow its progression, or effectively alleviate the associated cognitive and behavioral symptoms. The goal is to translate cutting-edge scientific discoveries into tangible, effective therapeutic options for individuals affected by Alzheimer’s, addressing a critical unmet medical need.
Opportunity ID: 336548
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-047 |
| Funding Opportunity Title: | Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 15, 2021 |
| Last Updated Date: | Nov 15, 2021 |
| Original Closing Date for Applications: | Nov 05, 2024 |
| Current Closing Date for Applications: | Nov 05, 2024 |
| Archive Date: | Dec 11, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses For profit organizations other than small businesses City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education State governments Independent school districts Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer’s disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-22-047.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 336548 Full Announcement-PAR-22-047 -> PAR-22-047-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270424 | Jan 05, 2022 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00270092 | Jan 05, 2022 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277955 | Nov 04, 2022 | Nov 05, 2024 | View |
Package 1
Mandatory forms
336548 RR_SF424_5_0-5.0.pdf
336548 PHS398_CoverPageSupplement_5_0-5.0.pdf
336548 RR_OtherProjectInfo_1_4-1.4.pdf
336548 PerformanceSite_4_0-4.0.pdf
336548 RR_KeyPersonExpanded_4_0-4.0.pdf
336548 PHS398_ResearchPlan_4_0-4.0.pdf
336548 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336548 RR_Budget_3_0-3.0.pdf
336548 RR_SubawardBudget30_3_0-3.0.pdf
336548 PHS398_ModularBudget_1_2-1.2.pdf
336548 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
336548 RR_SF424_2_0-2.0.pdf
336548 PHS398_CoverPageSupplement_5_0-5.0.pdf
336548 RR_OtherProjectInfo_1_4-1.4.pdf
336548 PerformanceSite_2_0-2.0.pdf
336548 RR_KeyPersonExpanded_2_0-2.0.pdf
336548 PHS398_ResearchPlan_4_0-4.0.pdf
336548 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
336548 RR_Budget_1_4-1.4.pdf
336548 RR_SubawardBudget30_1_4-1.4.pdf
336548 PHS398_ModularBudget_1_2-1.2.pdf
336548 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
336548 RR_SF424_5_0-5.0.pdf
336548 PHS398_CoverPageSupplement_5_0-5.0.pdf
336548 RR_OtherProjectInfo_1_4-1.4.pdf
336548 PerformanceSite_4_0-4.0.pdf
336548 RR_KeyPersonExpanded_4_0-4.0.pdf
336548 PHS398_ResearchPlan_5_0-5.0.pdf
336548 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336548 RR_Budget_3_0-3.0.pdf
336548 RR_SubawardBudget30_3_0-3.0.pdf
336548 PHS398_ModularBudget_1_2-1.2.pdf
336548 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
